Page last updated: 2024-12-06
allyl methyl disulfide
Description
Allyl methyl disulfide is a sulfur-containing organic compound with the formula CH2=CHCH2SSCH3. It is a colorless liquid with a pungent garlic-like odor. It is a naturally occurring compound found in garlic and other alliums. It has been reported to have a number of biological effects, including antimicrobial, anti-inflammatory, and antioxidant properties. Allyl methyl disulfide has also been shown to have anticancer effects in some studies. The compound is thought to exert its effects through its ability to react with cellular components, such as proteins and enzymes, and to modulate signaling pathways. Allyl methyl disulfide is a subject of ongoing research due to its potential therapeutic applications. Studies are being conducted to evaluate its efficacy in treating a range of conditions, including cancer, infections, and cardiovascular disease.'
allyl methyl disulfide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
allyl methyl disulfide : An organic disulfide having allyl and methyl as the two organic groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 62434 |
| CHEBI ID | 6854 |
| SCHEMBL ID | 548935 |
| SCHEMBL ID | 9535067 |
| MeSH ID | M0153916 |
Synonyms (40)
| Synonym |
|---|
| 3-(methyldisulfanyl)-1-propene |
| disulfide, methyl 2-propenyl |
| CHEBI:6854 |
| 3-(methyldisulfanyl)prop-1-ene |
| 3-(methyldithio)prop-1-ene |
| methyl 2-propenyl disulfide |
| methylallyl disulphide |
| 4,5-dithia-1-hexene |
| allyl methyl disulphide |
| C08383 |
| allyl methyl disulfide |
| 2179-58-0 |
| methyl allyl disulfide |
| AKOS006344179 |
| A815666 |
| oxw45utr7b , |
| ccris 3266 |
| einecs 218-549-1 |
| unii-oxw45utr7b |
| disulfide, allyl methyl |
| fema no. 3127 |
| FT-0634100 |
| SCHEMBL548935 |
| allyl methyl disulfide [fhfi] |
| disulfide, methyl-2-propenyl |
| SCHEMBL9535067 |
| mfcd00040023 |
| XNZOTQPMYMCTBZ-UHFFFAOYSA-N |
| 3-(methyldisulfanyl)-1-propene # |
| 2-propenylmethyldisulfide |
| DTXSID60176199 |
| fema 3127 |
| CS-0204953 |
| 1-allyl-2-methyldisulfane |
| Q27107347 |
| D88486 |
| allylmethyldisulfide |
| BS-44089 |
| ?methyl allylic ii sulfur ether |
| EN300-1610756 |
Roles (2)
| Role | Description |
|---|
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| volatile oil component | Any plant metabolite that is found naturally as a component of a volatile oil. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
| Class | Description |
|---|
| organic disulfide | Compounds of structure RSSR in which R and R' are organic groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 23.85 (24.57) | | Research Supply Index | 2.30 (2.92) | | Research Growth Index | 4.51 (4.65) | | Search Engine Demand Index | 23.28 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |